{"id":74737,"date":"2022-02-25T00:00:00","date_gmt":"2022-02-25T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2022\/02\/25\/antiseizure-treatment-explored-in-comatose-cardiac-arrest-survivors\/"},"modified":"2022-03-01T16:11:53","modified_gmt":"2022-03-01T16:11:53","slug":"antiseizure-treatment-explored-in-comatose-cardiac-arrest-survivors","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/02\/25\/antiseizure-treatment-explored-in-comatose-cardiac-arrest-survivors\/","title":{"rendered":"Antiseizure Treatment Explored in Comatose Cardiac Arrest Survivors"},"content":{"rendered":"<h3>\n<p>Strategy to suppress rhythmic and periodic EEG patterns did not improve neurologic outcomes at three months<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, Feb. 25, 2022 (HealthDay News) &#8212; For comatose survivors of cardiac arrest, the incidence of poor neurologic outcome at three months does not differ when a strategy to suppress rhythmic and periodic electroencephalographic (EEG) patterns is added to standard care, according to a study published in the Feb. 24 issue of the <em>New England Journal of Medicine<\/em>.<\/p>\n<p>Barry J. Ruijter, M.D., Ph.D., from the University of Twente in Enschede, Netherlands, and colleagues conducted an open-label trial of suppressing rhythmic and periodic EEG patterns detected on continuous EEG monitoring in cardiac arrest survivors who were comatose. Patients were randomly assigned to a stepwise strategy of antiseizure medications to suppress this activity for at least 48 hours plus standard care or to standard care alone (88 and 84 patients, respectively).<\/p>\n<p>The researchers found that complete suppression of rhythmic and periodic EEG activity for 48 hours occurred in 56 and 2 percent of patients in the antiseizure-treatment and control groups, respectively. At three months, a poor neurologic outcome occurred in 90 and 92 percent of patients in the antiseizure treatment and control groups, respectively (difference, 2 percentage points; 95 percent confidence interval, \u00e2\u0088\u00927 to 11; P = 0.68). At three months, mortality was 80 and 82 percent in the antiseizure treatment and control groups, respectively. Compared with the control group, the antiseizure-treatment group had a slightly longer mean length of stay in the intensive care unit and mean duration of mechanical ventilation.<\/p>\n<p>&#8220;Suppressing these EEG patterns during targeted temperature management after cardiac arrest offers no benefit in a population destined to do poorly,&#8221; writes the author of an accompanying editorial.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2115998\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe2118851\" target=\"_blank\" rel=\"noopener\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2021 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Strategy to suppress rhythmic and periodic EEG patterns did not improve neurologic outcomes at three months<\/p>\n","protected":false},"author":6,"featured_media":74897,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-74737","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/74737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=74737"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/74737\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/74897"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=74737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=74737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=74737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}